Fox Run Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Fox Run Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,148	Closed	-$478K	–	953
2022 Q3	$478K	Buy	10,148 +5,632	+125%	+$364K	0.19%	189
2022 Q2	$324K	Buy	+4,516	New	+$330K	0.16%	264
2017 Q4	–	Sell	-10,500	Closed	-$549K	–	937
2017 Q3	$549K	Buy	+10,500	New	+$585K	0.16%	256
2016 Q3	–	Sell	-13,700	Closed	-$522K	–	738
2016 Q2	$522K	Buy	13,700 +4,700	+52%	+$206K	0.25%	114
2016 Q1	$371K	Buy	+9,000	New	+$371K	0.25%	154

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fox Run Management's SYNH Position: Q4 2022 in Review

Fox Run Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 10,148 shares — an estimated $478K sold.

Fox Run Management first reported a position in SYNH in Q1 2016 and held it in 5 quarters. The position peaked at $549K in Q3 2017. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Fox Run Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Fox Run Management sold 10,148 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $478K.
Fox Run Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 5 quarters.
Fox Run Management's Syneos Health, Inc. Class A Common Stock position peaked at $549K in Q3 2017.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.